Open Access

Feasibility analysis of treating severe intrauterine adhesions by transplanting menstrual blood-derived stem cells

  • Authors:
    • Sheng‑Xia Zheng
    • Jian Wang
    • Xue‑Li Wang
    • Asim Ali
    • Li‑Min Wu
    • Yu‑Sheng Liu
  • View Affiliations

  • Published online on: January 23, 2018     https://doi.org/10.3892/ijmm.2018.3415
  • Pages: 2201-2212
  • Copyright: © Zheng et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Intrauterine adhesions (IUA) are associated with the loss of stem cells in the endometrium. Menstrual blood‑derived stem cells (MenSCs) can be isolated from the menstrual blood and differentiated into endometrial cells. To check the transplantation feasibility of MenSCs for the treatment of severe IUA, MenSCs were isolated from menstrual blood, cultured in Dulbecco's modified Eagle's medium (DMEM), identified by immunocytochemistry and flow cytometry, differentiated into endometrial cells in vitro, and finally transplanted into the axillary subcutaneous tissue of non‑obese diabetic/severe combined immunodeficiency (NOD‑SCID) mice to create endometrial tissue. Additionally, the cloning efficiency and POU domain class 5 transcription factor 1 (OCT‑4) positivity of MenSCs from patients with severe IUA were compared with those from healthy women. Immunocytochemistry and flow cytometry results showed that 95.1±0.8% cells were OCT‑4‑positive, 0.9±0.4% were cluster of differentiation (CD)45‑positive, 1.8±0.9% were STRO‑1‑positive and 1.0±0.4% were human leukocyte antigen‑antigen D related‑positive. Following differentiation in vitro, the results of immunocytochemistry, reverse transcription‑polymerase chain reaction and western blot analysis showed that the expression of cytokeratin (CK) and vimentin (VIM) was increased in MenSCs compared with that in control subjects. Subsequent to transplantation in mice administered with sequential 17β‑estradiol and progesterone, CK, VIM, estrogen receptor and progesterone receptor were expressed in the transplantation regions, suggesting that MenSCs could differentiate into endometrial tissues in vivo. The cloning efficiency and OCT‑4 positivity of MenSCs from patients with severe IUA was significantly decreased. In conclusion, to the best of our knowledge, this is the first study in which MenSCs could differentiate into endometrial cells in vitro and create endometrial tissue in NOD‑SCID mice in vivo, with impaired cloning efficiency and OCT‑4 expression of MenSCs from patients with IUA. This study will provide a theoretical basis for the treatment of IUA with MenSCs.
View Figures
View References

Related Articles

Journal Cover

April-2018
Volume 41 Issue 4

Print ISSN: 1107-3756
Online ISSN:1791-244X

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Zheng SX, Wang J, Wang XL, Ali A, Wu LM and Liu YS: Feasibility analysis of treating severe intrauterine adhesions by transplanting menstrual blood-derived stem cells. Int J Mol Med 41: 2201-2212, 2018.
APA
Zheng, S., Wang, J., Wang, X., Ali, A., Wu, L., & Liu, Y. (2018). Feasibility analysis of treating severe intrauterine adhesions by transplanting menstrual blood-derived stem cells. International Journal of Molecular Medicine, 41, 2201-2212. https://doi.org/10.3892/ijmm.2018.3415
MLA
Zheng, S., Wang, J., Wang, X., Ali, A., Wu, L., Liu, Y."Feasibility analysis of treating severe intrauterine adhesions by transplanting menstrual blood-derived stem cells". International Journal of Molecular Medicine 41.4 (2018): 2201-2212.
Chicago
Zheng, S., Wang, J., Wang, X., Ali, A., Wu, L., Liu, Y."Feasibility analysis of treating severe intrauterine adhesions by transplanting menstrual blood-derived stem cells". International Journal of Molecular Medicine 41, no. 4 (2018): 2201-2212. https://doi.org/10.3892/ijmm.2018.3415